Learning to distinguish progressive and non-progressive ductal carcinoma in situ-Reference-Cited by-同舟云学术

Learning to distinguish progressive and non-progressive ductal carcinoma in situ

Published:2022-10-19 Issue:12 Volume:22 Page:663-678
ISSN:1474-175X
Container-title:Nature Reviews Cancer
language:en
Short-container-title:Nat Rev Cancer

Author:

Casasent Anna K.,Almekinders Mathilde M.^ORCID,Mulder Charlotta^ORCID,Bhattacharjee Proteeti,Collyar Deborah^ORCID,Thompson Alastair M.,Jonkers Jos^ORCID,Lips Esther H.^ORCID,van Rheenen Jacco^ORCID,Hwang E. Shelley,Nik-Zainal Serena,Navin Nicholas E.^ORCID,Wesseling Jelle^ORCID,Sawyer Elinor J.,Davies Helen R.,Futreal Andrew,Navin Nicholas E.,Hwang E. Shelley,van Rheenen Jacco,Behbod Fariba,Schmidt Marjanka,Wessels Lodewyk F. A.,Rea Daniel,Stobart Hilary,Pinto Donna,Verschuur Ellen,van Oirsouw Marja,

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://www.nature.com/articles/s41568-022-00512-y.pdf

Reference217 articles.

1. Elshof, L. E. et al. Cause-specific mortality in a population-based cohort of 9799 women treated for ductal carcinoma in situ. Ann. Surg. 267, 952–958 (2018).

2. Roses, R. E. et al. Ductal carcinoma-in-situ of the breast with subsequent distant metastasis and death. Ann. Surg. Oncol. 18, 2873–2878 (2011).

3. Ernster, V. L., Barclay, J., Kerlikowske, K., Wilkie, H. & Ballard-Barbash, R. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch. Intern. Med. 160, 953–958 (2000).

4. Bleyer, A. & Welch, H. G. Effect of three decades of screening mammography on breast-cancer incidence. N. Engl. J. Med. 367, 1998–2005 (2012). This analysis of data on the incidence of DCIS, early-stage IBC and late-stage IBC from the Surveillance, Epidemiology, and End Results programme collected from 1976 to 2008 reveals that mammography screening has only marginally reduced the rate at which women present with advanced cancer, suggesting the existence of overdiagnosis.

5. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA Cancer J. Clin. 68, 7–30 (2018).

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial interpretation scores of screening mammograms and cancer detection in BreastScreen Norway;European Journal of Radiology;2024-10

2. The obese inflammatory microenvironment may promote breast DCIS progression;Frontiers in Immunology;2024-07-12

3. Towards targeting the breast cancer immune microenvironment;Nature Reviews Cancer;2024-07-05

4. The natural history of ductal carcinoma in situ: development, validation, and estimated outcomes of the SimDCIS model;2024-06-07

5. Estrogen receptor regulation of the immune microenvironment in breast cancer;The Journal of Steroid Biochemistry and Molecular Biology;2024-06